Discover 818 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 818
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Boston MA, Queens NY, The Bronx NY, Brooklyn NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase 3, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
for
Heart Failure
Location: Sherbrooke, Burlington VT, Norfolk VA, Greenville NC,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06033950
Phase 3, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
for
Heart Failure
Location: Sherbrooke, Montreal, Philadelphia PA, Norfolk VA,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06024746
Phase 3, Recruiting
A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
for
Juvenile Idiopathic Arthritis
Location: Calgary
Sponsor: Sanofi
Sex: All
Age: 1 - 17
Code: NCT02991469
Phase 2, Recruiting
Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial
for
Syncope
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 50 - 70+
Code: NCT05776810
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
for
Relapsing Remitting Multiple Sclerosis (RRMS)
Location: St. John's, Halifax, Montreal, Sherbrooke, Quebec,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06733922
Recruiting
Study of Whether 15 mg Dose of Ketorolac IV is as Effective as a 30 mg Dose.
for
Pain, Pain, Postoperative
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 65
Code: NCT01230463
Recruiting
Getting Global Rare Disease Insights Through Technology Study
Critical Delays in Cardiopulmonary Resuscitation During Simulated Obstetric Crisis: a Prospective Observational Study.
for
Maternal Death During Childbirth
Location: Calgary
Sponsor: KidSIM Simulation Program
Sex: All
Age: 18+
Code: NCT04050631
Recruiting
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
for
Pulmonary Arterial Hypertension
Location: Boston MA, Valhalla NY, New York NY, Durham NC,
Sponsor: Inhibikase Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07365332
Phase 3, Recruiting
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
for
Asthma
Location: Trois-Rivieres, Greenville NC, Columbia MD, Windsor,
Sponsor: Sanofi
Sex: All
Age: 6+
Code: NCT07556159
Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for
Pulmonary Arterial Hypertension (PAH),
Location: Philadelphia PA, Washington D.C. DC, Jacksonville FL,
Sponsor: AllRock Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07175038
Phase 2, Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Johnston RI, Quebec, New York NY, Chapel Hill NC,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07170917
Phase 2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Phase 4, Recruiting
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes